Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Deaglio

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
Blood|December 25, 2025
LEF1 and CLL: a matter of quantity and qualitySilvia Deaglio
Blood|August 11, 2022
Glutamine and CLL: ready for prime time?Silvia Deaglio
Blood|October 31, 2024
Toward a new paradigm for CLL treatmentSilvia Deaglio
Blood|September 14, 2023
Chemoresistance pathways in DLBCLSilvia Deaglio
Molecular & Cellular Oncology|September 26, 2018
Linking SLAMF1 to autophagy and sensitivity to therapy in chronic lymphocytic leukemiaCinzia Bologna, Silvia Deaglio
Blood|February 3, 2022
A new taxonomy for splenic marginal zone lymphomaSilvia Deaglio, Tiziana Vaisitti
Haematologica|June 2, 2009
Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferationSilvia Deaglio, Fabio Malavasi
Purinergic Signalling|May 3, 2024
Role of CD73 and the purinergic signaling pathway in the pathogenesis of fusion-negative rhabdomyosarcomaAmelia Fascì, Silvia Deaglio
Pediatric Nephrology (Berlin, Germany)|January 17, 2023
Rejection markers in kidney transplantation: do new technologies help children?Licia Peruzzi, Silvia Deaglio
Handbook of Experimental Pharmacology|March 10, 2017
Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic LeukemiaFrancesca Arruga, Silvia Deaglio
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
Blood|December 25, 2025
LEF1 and CLL: a matter of quantity and qualitySilvia Deaglio
Blood|August 11, 2022
Glutamine and CLL: ready for prime time?Silvia Deaglio
Blood|October 31, 2024
Toward a new paradigm for CLL treatmentSilvia Deaglio
Blood|September 14, 2023
Chemoresistance pathways in DLBCLSilvia Deaglio
Molecular & Cellular Oncology|September 26, 2018
Linking SLAMF1 to autophagy and sensitivity to therapy in chronic lymphocytic leukemiaCinzia Bologna, Silvia Deaglio
Blood|February 3, 2022
A new taxonomy for splenic marginal zone lymphomaSilvia Deaglio, Tiziana Vaisitti
Haematologica|June 2, 2009
Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferationSilvia Deaglio, Fabio Malavasi
Purinergic Signalling|May 3, 2024
Role of CD73 and the purinergic signaling pathway in the pathogenesis of fusion-negative rhabdomyosarcomaAmelia Fascì, Silvia Deaglio
Pediatric Nephrology (Berlin, Germany)|January 17, 2023
Rejection markers in kidney transplantation: do new technologies help children?Licia Peruzzi, Silvia Deaglio
Handbook of Experimental Pharmacology|March 10, 2017
Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic LeukemiaFrancesca Arruga, Silvia Deaglio
Pageof 20